Transdermal Therapeutic System (TTS) Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The global transdermal therapeutic system (TTS) market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The TTS is a type of drug delivery system that can deliver drugs through skin portals directly to the bloodstream. The rise in the prevalence of chronic diseases such as diabetes, CVDs, and others coupled with the rising geriatric population who require TTS is anticipated to drive the growth of the market.

For instance, according to IDF Diabetes Atlas Tenth Edition 2021, approximately 537 million people, between the age of 20-79 years are living with diabetes and the total number is projected to rise to 643 million by 2030, 783 million by 2045. More than 1.2 million children and adults are living with type -1 diabetes and 541 million adults are at an increased risk of developing type -2 diabetes. According to IDF, diabetes has caused more than 6.7 million mortalities globally.  Furthermore, according to WHO, an estimated 17.9 million mortalities occurred due to CVD in 2019, representing 32.0% of all global mortalities.

Looking toward the demand for TTS, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, the USFDA had approved Adlarity (Donepezil Transdermal System) for mild, moderate, and severe dementia of the Alzheimer’s type. Thus, such approvals are anticipated to drive the growth of the global TTS market over the forecast period (2022-2028)

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- GlaxoSmithKline Plc, Novartis International AG, and Dr. Reddy’s Laboratories Ltd. among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Transdermal Therapeutic System (TTS) Market Report by Segment

By Type

• Methyl Salicylate
• Nicotine
• Nitroglycerin
• Fentanyl
• Rivastigmine
• Estradiol
• Others

By Distribution Channel

• OTC Channel
• Retail Channel
• Online Channel